(3S)-(-)-3-(tert-Butoxycarbonylamino)pyrrolidine>98.0%(GC)(T)5g

N-(3-acetylphenyl)guanidine, 95.0%, 1g

4-Fluoro-3-methylbenzoyl chloride, 97.0%, 5g

M-cymene, 97%, 1g

METHYL 3-CHLORO-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE, 95.0%, 250mg

4-Fluorophenylacetone, 98.0%, 25g

5-chloro-3-[(4-methoxyphenyl)methyl]-1,2,4-thiadiazole, 95.0%, 10g

m-PEG24-NH2, 1g

GC capillary column ROTI®Cap-1 MS, 30 m, 0.25 mm, 0.25 µm, 1 Piece(s)

BISMUTH(III) ACETATE, 95%, 10g

2-methyl-1-[4-(trifluoromethyl)benzoyl]piperazine, 95.0%, 2g

(S)-2-(benzylamino)-4-(tert-butoxy)-4-oxobutanoic acid, 95%, 1g

2-Thien-2-ylisonicotinonitrile, 97.0%, 10g